cafepharma news hand selected daily
get news headlines in your inbox each weekday

Daiichi Sankyo

Tagged:

Plavix Label Change: Good For Effient Now, Bad For Brands in the Long Run?

InVivo

Login or register to post comments

Tagged:

Ranbaxy: FDA Issues Will Take Long Time To Resolve

WSJ Online

Login or register to post comments

Tagged:

Effient and Onglyza Start Slow—And That May Not Be A Bad Thing

InVivo

Login or register to post comments

Tagged:

MorphoSys, Daiichi Sankyo Enter Alliance to Develop Antibodies

Bloomberg

Login or register to post comments

Tagged:

Strange Bedfellows: Rival Medical Firms Launch Joint Stent Study

WSJ Online

Login or register to post comments

Tagged:

Study: Patients using Effient cost less

Fierce Pharma

Login or register to post comments

Tagged:

Japan's Daiichi Sankyo says new flu drug effective

Google/AFP

Login or register to post comments

Tagged:

Daiichi Sankyo Posts First-Quarter Loss on Ranbaxy

Bloomberg

Login or register to post comments

Tagged:

Is Lilly's Effient Sufficient?

CNBC

Login or register to post comments

Tagged:

How dangerous is Effient to Plavix?

Fierce Pharma

Login or register to post comments

New on Cafepharma

Funny or interesting conversations reps hear in the field
Overheard in the Field
Keep up with the latest at cafepharma:
follow us on twitter
GE Healthcare IT
HIV Reps
New message boards
Baxter IT
Pacific Pulmonary Services
Pacific Pulmonary Services IT
New message board category
Pharma IT Boards

<a href="http://finance.yahoo.com">Yahoo! Finance</a><br/><a href="http://finance.yahoo.com/q?s=ABT">Quote for ABT</a>